Abstract
Background: Laelia furfuracea is an orchid with anticoagulant properties; however, it is unknown which coagulation factors are inhibited and whether the plant has antiplatelet activity. Questions: Does the hydroethanolic extract of leaves of L. furfuracea inhibit coagulation factor activity and platelet aggregation? Studied species: Laelia furfuracea. Study site and dates: Plant material was collected in April 2023 in Santo Domingo Yanhuitlán, Oaxaca, Mexico. Methods: The anticoagulant and antiplatelet effects of the extracts of L. furfuracea were evaluated in samples from patients with thrombosis through coagulometric assays and light transmission aggregometry. Results: The extract of L. furfuracea inhibited the activity of factors II, V, VIII, and XI in a concentration-dependent manner. The highest extract concentration, 14.0 mg/mL, inhibited about 60 % of factors II and V activity, but ˃ 95 % of factors VIII and XI. Moreover, at a 1.0 mg/mL concentration, the extract inhibited platelet aggregation induced by ADP, thrombin, and epinephrine in 85, 97, and 83 %, respectively. Conclusions: It was demonstrated that the orchid extract inhibits both the activity of factors II, V, VIII, XI, and thrombin-, ADP-, and epinephrine-induced platelet aggregation. Polyphenols stand out among the possible bioactive compounds of the orchid with anticoagulant and/or antiplatelet activity.

This publication has 70 references indexed in Scilit: